Several gene-or set-based association tests have been proposed recently in the literature. Powerful statistical approaches are still highly desirable in this area. In this paper we propose a novel statistical association test, which uses information of the burden component and its complement from the genotypes. This new test statistic has a simple null distribution, which is a special and simplified variance-gamma distribution, and its p-value can be easily calculated. Through a comprehensive simulation study, we show that the new test can control type I error rate and has superior detecting power compared with some popular existing methods. We also apply the new approach to a real data set; the results demonstrate that this test is promising.
SKAT-O statistic is intractable and numeric method is required to estimate the p-value. 4 More seriously, our study shows that the SKAT-O may have inflated type I error rate (see the simulation study section).
In this report, we propose a novel statistical test which combines the information from the burden test and its complement in an efficient way so that the new test statistic has a simple null distribution from which the p-value can be easily calculated. In addition, through a comprehensive simulation study, we show that the proposed test is more powerful than others under many situations. We also apply our new test to a real data to demonstrate its application.
Methods
In this report, we use the following notations: m, the number of SNPs in a set, n, the number of subjects in the study, y ¼ ðy 1 , y 2 , . . . , y n Þ T , the adjusted phenotypes (standardized residuals from a GLM which adjusts for nongenetic co-variates), where T denotes the matrix transpose. We use n Â m matrix G nÂm to denote the genotype data, where the element of G, g ij À Á ¼ 0, 1, or 2ði ¼ 1, 2, . . . , n; j ¼ 1, 2, . . . , mÞ, the number of minor alleles of the j th SNP from the i th subject. Note that asymptotically, y can be treated as n independent samples from a standard normal distribution Nð0, 1Þ. In addition, we define K ¼ GG T .
Some existing tests
The SKAT statistic is defined as 5 
SKAT ¼ y T Ky ð1Þ
It can be shown that under the null hypothesis that none of the m SNPs is associated with the adjusted phenotype y, SKAT asymptotically follows a linear combination of chi-square distributions. More specifically, SKAT $ P k i¼1 i 2 i,1 where i are the none-zero eigenvalue of K and 2 i,1 are independently identically distributed (iid) chi-square distribution with degree of freedom (df) equals to 1. The set of none-zero eigenvalues i can also be calculated from the m Â m matrix G T G as G T G and GG T have the same set of none-zero eigenvalues. The latter calculation is more efficient when n 4 m. The p-value for SKAT can be estimated using the Davis method. 5, 12 The burden test statistic is defined as
g ij =m and g ij is the ði, j Þ element of matrix G, then " z ¼ G1=m where 1 is the m Â 1 column vector with all elements equal to 1.
The burden test statistic is proportional to the following statistic
It is easy to show that under the null hypothesis, the test statistic B 0 asymptotically follows a chi-square distribution with df equal to 1.
For any real number satisfying 0 1, define
where p is the p-value from the test S . The two statistics B and SKAT are correlated and the null distribution of SKATO is intractable. 4 A numeric method is usually used to estimate the p-value for SKATO. 
The proposed test
We define the following statistic
Note that M determinates the contribution from the burden test, and I À M is complementary to M as it can be shown that M is an idempotent matrix and I À M ð ÞM ¼ 0: To study the properties of T, we need the following lemmas. Lemma 1. If XNð, AEÞ, then for symmetric matrices A and B, we have
Proof. See 20.18 (a) (p434) and 20.25 (c) (ii) and (iii) (p438) of Seber.
13
For the variance of the statistic T in equation (5), we have the following property.
Proof. Note that here y $ Nð0, IÞ, from lemma 1,
. Similarly, we have
From the proof of lemma 2, we have the following result. Proof. Since T ¼ y T By and B ¼ ðA þ A T Þ=2 6 ¼ 0 is symmetric, the quadratic form of T can be written as
, where i and i are the eigenvalues and eigenvectors of B. Under the null hypothesis,
Hence, since B 6 ¼ 0, the number of non-zero eigenvalues of B rankðBÞ 2 (See p95, 6.16 (a) of Seber 13 ).
The proposed test is called VGAT (Variance-Gamma Association Test) and defined as
For S in equation (6), we have the following results.
Theorem 2. Asymptotically, under the null hypothesis, if 6 ¼ 0, the new test statistic in equation (6) S $ variance À gamma distribution with the location parameter c ¼ 0, the spread parameter ¼ 1, the asymmetry parameter ¼ 0, and the shape parameter ¼ 2 for the probability density function . Therefore, it follows the claimed variance-gamma distribution. 14 The two-sided p-value from the new test statistic S with the observed statistic s is defined as P ¼ ProbðS 4 jsjÞ, which can be approximated using the Davis method when 6 ¼ 0. 12 For instance, we can use function davisðÁÞ from the R package ''CompQuadForm'' (https://cran.r-project.org/web/packages/CompQuadForm/index.html).
Since the type I error rates using the Davis approximation for both S with (i.e. SKAT) and without ¼ 0 under the null hypothesis asymptotically equal to the preset significance level, we have the following result.
Theorem 3. Using the Davis approximation, the test statistic S can asymptotically control type I error rate.
Simulations study
In this section, we investigate the property of the new test through simulation study based on genotypes of real data. In this report, for the SKAT, SKAT-O and the burden tests, we use the R package ''SKAT'' (https://cran.rproject.org/web/packages/SKAT/index.html) to get their p-values.
The GWA17 data
First, we apply the new method and others to the Genetic Analysis Workshop 17 (GAW17) data. The GAW17 uses the information of a subset of genes with sequencing data available in the 1000 Genomes Project. In GAW17, SNPs from the gene ELAVL4 influence the simulated quantitative phenotype Q 1 . Except for the genetic risk factors, Q 1 was also assumed to be associated with some covariates, such as age, gender, and smoking status. For this gene, a total of 200 simulated phenotypes (Q 1 values) were conducted in the GAW17 data set. First we used a linear regression model to account for the effects of those non-genetic factors, then we applied our proposed test, along with SKAT, SKAT-O and the burden test, to the standardized residuals obtained from the regression step. Figure 1 plots the -log10(p-values) obtained by the four methods. This plot clearly shows that the proposed test produces smaller p-values compared to SKAT, SKAT-O, and the burden test, for most of the cases. This indicates that the proposed test VGAT is more powerful than the other methods. For some cases, the improvements of the VGAT were substantial.
Simulation study
To conduct sensible simulation study, we use the genotypes of gene ELAVL4 from the GAW17 study as they are from real genetic data. For the gene ELAVL4, there are 10 SNPs and 697 subjects without missing genotypes. To keep the true genotype structure, we will remain the genotype data unchanged in the simulation study.
To mimic the real situation, we simulate two none-genetic covariates: one is binary and the other is from a normal distribution. For each subject, we simulate the phenotype using the following formula
where
5Þ, g ij is the genotype of the j th SNP from the i th subject, and e i $ Nð0, 1Þ. For the coefficients j ð j ¼ 1, 2, . . . , 10Þ, we consider several different settings. To obtain the empirical type I error rates, we set all j ¼ 0. To compare the detecting powers, we randomly choose a portion () of SNPs as causal SNPs and the rest as non-causal variants whose coefficients are set to be 0. Among those causal variants, we randomly assign a portion (r) to have positive effects and let the remaining with negative effects. For those causal SNPs, we first follow the suggestion from the SKAT paper 5 and set the effect size as a function of the MAF, j j j ¼ Àd Â log 10ðMAF j Þ, where MAF j is the MAF of the j th SNP. We then consider the situation where the effect sizes are independent of MAF, j j j ¼ 3d. For the constant d, we use different values, 0.5 and 1. In this simulation study, we use different significances levels so that the power values are appreciable. Table 1 reports the empirical type I error rates from the four methods using different significance levels (). The SKAT test, the burden test and the proposed test can control type I error rate for most of the situations considered. However, surprisingly, we notice that the SKAT-O test had inflated type I error rates for all of the conditions. To further investigate their performance under the null hypothesis, we plotted the histograms of the null p-values in Figure 2 better power values than the SKAT which in turn performed better than the burden test. However, caution should be taken when we compare SKAT-O with others as we have already noticed that the SKAT-O may have inflated type I error rate. With different values of d and , we had similar observations (see Supplemental Tables S1 and S2 where d ¼ 0.5 and ¼ 10 À2 were used).
Real data application
In this section, we apply the proposed test along with others to a real data, the ocular hypertension treatment study (OHTS) data. 15 OHTS is a National Eye Institute-sponsored multi-center, randomized clinical trial. Its goal was to investigate the efficacy of medical treatment in delaying or preventing the onset of primary open angle glaucoma (POAG) in individuals with elevated intraocular pressure. Data set for this genetic study is available at Database of Genotypes and Phenotypes (dbGaP, Study Accession phs000240.v1.p1). There were 1,051,295 genotyped SNPs. The HGNC gene symbols were obtained using the R/Bioconductor package biomaRt (version 2.26.1) and 30,562 autosomal genes were included.
In this application, we want to detect the association between each gene and the outcome central corneal thickness (CCT), which is used to assess POAG in this study. Two hundred and forty-nine non-Hispanic Black samples are used in this application. After adjusting for covariates age and gender using a linear regression, the standardized residues from the regression analysis are used for the association tests. To detect possible associated genes, we list all genes whose smallest p-values from the four methods are less than 2:5 Â 10 À5 . Using this criterion, three genes were found and listed in Table 4 which also reports the p-values from the four methods. For all of the three listed genes, the proposed test had the smallest p-values. For two genes (IKBKE and GHDC), all of the three other methods obtained very large p-values (all greater than 0.05). However, it warrants further investigations to determine whether the three listed genes are true positives.
Discussion and conclusion
In this report, we propose a novel gene-or set-based association test, VGAT. This new test has relatively simple null distribution and its p-value can be easily calculated using currently available statistical tool. Through simulation study and real data application, we have shown that the new method could control type I error rate and had superior detecting power compared with some popular existing methods. We expect that more significant associated genes or sets of variants can be identified when our proposed test is applied to existing genetic data. In addition, the proposed method can be applied to common variants, rare variants, or a set with both common and rare variants. However, like any population based association tests, when the proposed test is applied to real data, we need adjust for the possible population stratification effect, which may produce spurious association. For example, the principal component analysis based method can be used when we have subjects from multiple races/ethnics. 16 From the definition of T in equation (5), we can rewrite it as T ¼ ½y T MK½y T ðI À MÞ T , where y T M is the contribution from the burden test while y T ðI À MÞ is from the complement of the burden test. Therefore, the proposed test combines information for both the burden test and its complementary part. On the other hand, the SKAT-O tries to combine information from the burden test and another term which is not independent of the burden test. As a consequence, the SKAT-O has intractable null distribution and the p-value from the numeric method implemented in the R package ''SKAT'' may cause inflated type I error rate as observed from our simulation study. Because of this, we should use SKAT-O with caution.
Our proposed method is also computationally efficient. We used the real data set to compare the computational burden for those methods. All of the tests were implemented in R. The running times were obtained when they were run in a computer with 3.60 GHz Intel Core processors and 8 GB of RAM memory. The running times are 0.47, 3.62, 0.45, and 0.42 hours for the SKAT, SKAT-O, burden, and the proposed method, respectively. 
